RTI Surgical
Develops and manufactures surgical implants using additive manufacturing for PEEK and metal spinal implants, with a focus on biologics and synthetic materials.
- CEO / Founder
- Camille Farhat
- Team Size
- 501-1000
- Stage
- Acquired
- Total Funding
- $281M
- Latest Round
- IPO
- Key Investors
- Water Street Healthcare Partners
Technology & Products
Key Products
Fortilink family; TETRAfuse; nanOss; Map3
Technological Advantage
Proprietary additive manufacturing processes for spinal implants, with FDA-cleared products.
Differentiation
Value Proposition
Provides advanced spinal implants with improved osseointegration through additive manufacturing, reducing surgery time and improving patient outcomes.
How They Differentiate
Focus on biologics and synthetic implants with AM capabilities, combined with a broad portfolio of tissue-based products.
Market & Competition
Target Customers
Hospitals, surgeons, medical device distributors
Industry Verticals
Medical; Orthopedics
Competitors
Oxford Performance Materials; Stryker; Zimmer Biomet
Growth & Milestones
Growth Metrics
Worldwide revenues were $280.9 million for the full year 2018, an increase of 4.4% from 2017; Q4 2018 revenue was $71.3 million
Major Milestones
Acquired Pioneer Surgical Technology (2013); Acquired Zyga Technology (2018); Acquired Paradigm Spine (2019); Acquired Collagen Solutions (2019)
Notable Customers
Medtronic Sofamor Danek USA, Inc.; Zimmer Biomet